Daiichi unit bids for rest of Challenger

TAL Daiichi Life Australia Pty, part of Japan’s Daiichi Life Group, has submitted a non-binding, indicative proposal to acquire all Challenger Limited shares it does not already own. The indicative proposal offers A$11.80 in cash per Challenger share, in a deal that would take the Australian investment manager into full ownership by the Daiichi Life unit if completed.

At A$11.80 per share, the proposal values Challenger at about A$7.94 billion, or roughly $5.53 billion. The proposed offer price represents a 19.8% premium to Challenger’s last closing share price, providing a significant uplift relative to the most recent market level.

TAL Daiichi Life Australia already holds a minority position in Challenger and is seeking to acquire more than 79% of the company’s ordinary shares through this proposal. Several reports describe the intended transaction structure as a scheme of arrangement at the stated offer price.

Challenger has characterised the approach as non-binding and indicative, meaning it does not yet constitute a final, enforceable takeover agreement. The proposal remains subject to a series of conditions before it can proceed to a definitive deal.

Key conditions include the satisfactory completion of due diligence on Challenger by TAL Daiichi Life Australia. The parties would also need to negotiate and enter into a scheme implementation agreement on terms acceptable to both sides, setting out the detailed mechanics and obligations for the proposed acquisition.

In addition, the transaction would require various regulatory approvals. These would be necessary for the scheme of arrangement structure to take effect and for TAL Daiichi Life Australia to move from a minority stake to full ownership of Challenger’s remaining shares.

Challenger has stated that its board is currently considering the indicative proposal from TAL Daiichi Life Australia. A key condition of the offer proceeding is that the Challenger board ultimately provides a recommendation in favour of the scheme to shareholders.

Until that assessment is complete, Challenger has advised its shareholders that they do not need to take any action in response to the proposal. Further details such as final terms, regulatory timelines and any formal scheme implementation agreement have not been disclosed at this stage.

If the conditions are met and a binding scheme is agreed, the transaction would result in TAL Daiichi Life Australia acquiring the more-than-79% of Challenger shares it does not already own at the A$11.80 offer price. For now, the process remains at an early, exploratory phase while due diligence and negotiations progress.